Katarina Raslova

Summary

Affiliation: Metabolic Center
Country: Slovakia

Publications

  1. ncbi Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes
    K Raslova
    Metabolic Center, Institute of Preventive and Clinical Medicine, Limbova 14, 833 01 Bratislava, Slovak Republic
    Diabetes Res Clin Pract 66:193-201. 2004
  2. ncbi Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index
    Katarina Raslova
    Metabolic Center Ltd and Slovak Medical University, Bratislava, Slovak Republic
    Clin Drug Investig 27:279-85. 2007
  3. pmc An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog
    Katarina Raslova
    Metabolic Center Ltd and Slovak Medical University, Bratislava, Slovak Republic
    Vasc Health Risk Manag 6:399-410. 2010

Detail Information

Publications3

  1. ncbi Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes
    K Raslova
    Metabolic Center, Institute of Preventive and Clinical Medicine, Limbova 14, 833 01 Bratislava, Slovak Republic
    Diabetes Res Clin Pract 66:193-201. 2004
    ....
  2. ncbi Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index
    Katarina Raslova
    Metabolic Center Ltd and Slovak Medical University, Bratislava, Slovak Republic
    Clin Drug Investig 27:279-85. 2007
    ..This pooled analysis investigated whether this potential advantage is related to body mass index (BMI) when insulin detemir is used as the basal component of basal-bolus therapy...
  3. pmc An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog
    Katarina Raslova
    Metabolic Center Ltd and Slovak Medical University, Bratislava, Slovak Republic
    Vasc Health Risk Manag 6:399-410. 2010
    ..The properties of insulin detemir match these requirements...